Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma

Xiaoli Zhou,Ya-Na Zhou,Ashaq Ali,Cuiqin Liang,Zhiqin Ye,Xiaomin Chen,Qing Zhang,Lihua Deng,Xinyi Sun,Qian Zhang,Jihong Luo,Wei Li,Kun Zhou,Shanshan Cao,Xiaowei Zhang,Xiao-Dong Li,Xian-En Zhang,Zongqiang Cui,Dong Men
DOI: https://doi.org/10.3389/fimmu.2021.701295
IF: 7.3
2021-07-28
Frontiers in Immunology
Abstract:The current pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already become a global threat to the human population. Infection with SARS-CoV-2 leads to a wide spectrum of clinical manifestations. Ocular abnormalities have been reported in association with COVID-19, but the nature of the impairments was not specified. Here, we report a case of a female patient diagnosed with glaucoma on re-hospitalization for ocular complications two months after being discharged from the hospital upon recovery from COVID-19. Meanwhile, the patient was found re-positive for SARS-CoV-2 in the upper respiratory tract. The infection was also diagnosed in the aqueous humor through immunostaining with antibodies against the N protein and S protein of SARS-CoV-2. Considering the eye is an immune-privileged site, we speculate that SARS-CoV-2 survived in the eye and resulted in the patient testing re-positive for SARS-CoV-2.
immunology
What problem does this paper attempt to address?